Rat-Bite Fever (Streptobacillus moniliformis)

Comprehensive Clinical Guide: Rat-Bite Fever (Streptobacillus moniliformis)

Rat-Bite Fever (RBF) is a rare, systemic zoonotic disease caused by Streptobacillus moniliformis in North America and Spirillum minus (causing Sodoku) in Asia. As a clinical entity, S. moniliformis is a facultatively anaerobic, pleomorphic, Gram-negative bacillus that resides in the oropharynx of healthy wild and laboratory rats. Given the potential for rapid systemic progression and significant morbidity if left untreated, it remains a critical diagnosis for clinicians in emergency and infectious disease settings.

1. Etiology and Pathophysiology

Streptobacillus moniliformis is highly fastidious and notoriously difficult to culture, often requiring specialized media supplemented with serum or blood. The organism is primarily transmitted through the bite or scratch of an infected rodent, or through the consumption of food or water contaminated with rodent excreta (a condition historically termed Haverhill fever).

The Mechanism of Infection

Upon inoculation, the bacterium gains entry into the bloodstream. Unlike many localized bacterial infections, RBF is inherently systemic. The pathophysiology involves:
* Bacteremic Seeding: Rapid dissemination to joints, heart valves, and soft tissues.
* Immune Complex Deposition: The hallmark migratory polyarthralgia is largely attributed to the deposition of immune complexes in the synovial spaces.
* Endothelial Interaction: The organism has a high affinity for synovial endothelium and cardiac valves, increasing the risk of endocarditis.

2. Clinical Staging and Standard Presentation

The clinical course of RBF is generally divided into a classic triad of fever, rash, and polyarthralgia.

Clinical Presentation Timeline

Diagnostic Staging Criteria

1. Systemic Inflammatory Response: Sustained fevers (>38.5°C).
2. Dermatological Involvement: Rash appearing on the extremities, often progressing to involve the palms and soles.
3. Articular Involvement: Intense joint pain, swelling, and redness, particularly in large joints (knees, elbows, ankles).

3. Differential Diagnosis

The clinical presentation of RBF is nonspecific, often mimicking other febrile illnesses. Accurate diagnosis requires excluding:

• Rocky Mountain Spotted Fever (RMSF): Shares the petechial rash distribution but usually lacks the intense polyarthralgia.
• Disseminated Gonococcal Infection: A primary differential for migratory polyarthritis and rash in sexually active adults.
• Lyme Disease: Early disseminated stages can present with systemic symptoms and arthralgia, though the rash morphology (erythema migrans) is distinct.
• Leptospirosis: Often linked to rodent exposure; characterized by conjunctival suffusion and renal/hepatic involvement.
• Endocarditis (Culture-Negative): Given the risk of S. moniliformis endocarditis, it must be considered in patients presenting with new murmurs.

4. Key Diagnostic Tests and Clinical Procedures

Because S. moniliformis is pleomorphic and slow-growing, laboratory identification is challenging.

Laboratory Workup

1. Blood Cultures: The gold standard. Must notify the laboratory of suspected RBF, as the organism is inhibited by sodium polyanethol sulfonate (SPS) in standard blood culture bottles.
2. Synovial Fluid Analysis: Often reveals an inflammatory profile with high white blood cell counts (predominantly neutrophils).
3. 16S rRNA PCR: Increasingly utilized for rapid confirmation when culture results are negative or delayed.
4. Serology: Indirect fluorescent antibody (IFA) assays are available but lack widespread clinical availability.

5. Treatment Protocols and Prognosis

Pharmacological Management

• First-Line: Penicillin G (intravenous) is the treatment of choice for 5–7 days, followed by oral Penicillin V.
• Alternative (Penicillin-allergic): Doxycycline or Ceftriaxone.
• Duration: If endocarditis or osteomyelitis is suspected, treatment must be extended to 4–6 weeks.

Long-term Prognosis

With prompt antibiotic therapy, the prognosis is excellent. However, failure to treat can lead to severe complications:
* Septic Arthritis: May result in permanent joint deformity.
* Endocarditis: A life-threatening complication requiring surgical intervention in some cases.
* Abscess Formation: Soft tissue or deep organ abscesses may occur in untreated chronic cases.

6. FAQ: Frequently Asked Questions

1. Can RBF be transmitted by a pet rat?
Yes. While wild rats are the primary reservoir, pet store or domestic rats can carry the bacteria in their oropharynx.

2. Is the bite wound always visible at the time of fever?
No. In most cases, the bite wound heals within a few days, often before the systemic symptoms appear.

3. Why is it called "Haverhill Fever"?
Haverhill fever is the term used for the ingestion-based transmission of S. moniliformis (e.g., via contaminated milk or water), first described in Haverhill, Massachusetts.

4. What is the mortality rate if left untreated?
Untreated RBF carries a mortality rate of approximately 10% to 13%, primarily due to complications like endocarditis or myocarditis.

5. Does the rash always appear?
The rash is a classic sign but is not present in every case. Its absence should not rule out RBF in a patient with a history of rodent exposure.

6. Are there any specific lab alerts I should include?
Yes. Always notify the lab of "potential Rat-Bite Fever" so they avoid using SPS-containing media, which can kill the organism.

7. Can the arthritis become permanent?
If treatment is delayed, chronic joint pain and structural damage can occur, though this is rare with modern antibiotic regimens.

8. Is there a vaccine for RBF?
Currently, there is no vaccine available for Streptobacillus moniliformis.

9. How is it distinguished from Spirillum minus?
S. minus (Sodoku) typically features an ulcerating bite wound and regional lymphadenopathy, which are uncommon in S. moniliformis infections.

10. How long does the fever last without treatment?
The fever can be relapsing or remitting for weeks or months if the infection is not treated with appropriate antibiotics.

7. Risks, Side Effects, and Contraindications

Clinical Warnings

• Jarisch-Herxheimer Reaction: Clinicians should be aware of a potential systemic reaction shortly after the initiation of antibiotic therapy due to the release of endotoxins from dying bacteria.
• Antibiotic Resistance: While S. moniliformis is generally susceptible to penicillin, the presence of localized abscesses may require surgical drainage (debridement) in addition to systemic therapy.
• Pregnancy: While rare, infection during pregnancy is associated with high fetal morbidity and mortality. Immediate aggressive treatment is mandated.

Contraindications

• Avoid Suboptimal Dosing: Inadequate duration of therapy significantly increases the risk of relapse.
• SPS Interference: Never perform blood cultures using standard anticoagulants that inhibit S. moniliformis without consulting your pathology department for specialized transport media.

8. Conclusion for the Specialist

Rat-Bite Fever remains a diagnostic challenge due to its low incidence and the fastidious nature of the causative organism. The clinical suspicion must be high in any patient presenting with unexplained fever, migratory polyarthralgia, and a history of rodent exposure. Early identification, proper laboratory communication, and prompt initiation of Penicillin-based therapy are the cornerstones of successful management. By adhering to the diagnostic algorithms outlined in this guide, clinicians can effectively reduce the risk of severe, life-threatening complications such as endocarditis and permanent articular disability.

Disclaimer: This guide is intended for educational and clinical reference purposes for healthcare professionals. It does not replace institutional protocols or direct consultation with Infectious Disease specialists.